Page last updated: 2024-09-05

lapatinib and sofosbuvir

lapatinib has been researched along with sofosbuvir in 1 studies

Compound Research Comparison

Studies (lapatinib)	Trials (lapatinib)	Recent Studies (post-2010) (lapatinib)	Studies (sofosbuvir)	Trials (sofosbuvir)	Recent Studies (post-2010) (sofosbuvir)
1,919	305	1,442	2,164	318	2,064

Protein Interaction Comparison

Protein	Taxonomy	lapatinib (IC50)	sofosbuvir (IC50)
Cytochrome P450 3A4	Homo sapiens (human)		8.4

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kassem, H; Kassem, N; Talima, S	1

Other Studies

1 other study(ies) available for lapatinib and sofosbuvir

Article	Year
Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection. Breast cancer (Tokyo, Japan), 2019, Volume: 26, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Breast Neoplasms; Breast Neoplasms, Male; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Lapatinib; Liver; Male; Middle Aged; Retrospective Studies; Sofosbuvir; Trastuzumab; Virus Replication	2019

Article

Year

Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection.

Breast cancer (Tokyo, Japan), 2019, Volume: 26, Issue:2

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Breast Neoplasms; Breast Neoplasms, Male; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Lapatinib; Liver; Male; Middle Aged; Retrospective Studies; Sofosbuvir; Trastuzumab; Virus Replication

2019